Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Solid Tumors

This study has been completed.
Sponsor:
Collaborator:
Georgetown University
Information provided by:
INSYS Therapeutics Inc
ClinicalTrials.gov Identifier:
NCT00024661
First received: September 24, 2001
Last updated: April 12, 2011
Last verified: April 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: October 2004
  Primary Completion Date: No date given